| Literature DB >> 34078353 |
Chun-Ming Liao1,2, Wen-Hao Huang3, Pei-Tseng Kung4,5, Wen-Chen Tsai6, Li-Ting Chiu7.
Abstract
BACKGROUND: The World Health Organization has recognized that people with disability are among the most marginalized in the world. This study's objective was to investigate the differences in the probability of colorectal cancer (CRC) screening with faecal immunochemical testing (FIT) between people with disability and without disability in Taiwan.Entities:
Keywords: Colorectal cancer; Colorectal cancer screening; Disability
Year: 2021 PMID: 34078353 PMCID: PMC8170777 DOI: 10.1186/s12889-021-11105-z
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Process of selecting the study participants meeting the CRC screening criteria
The Use of FIT for CRC Screening in People with Disability
| No FIT | FITa | |||||||
|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | |||
| 299,107 | 100.00 | 233,778 | 78.16 | 65,329 | 21.84 | |||
| < 0.001 | ||||||||
| Moving functional limitation | 144,953 | 48.46 | 111,976 | 77.25 | 32,977 | 22.75 | ||
| Internal organ function loss and related disabilities | 41,344 | 13.82 | 33,518 | 81.07 | 7826 | 18.93 | ||
| Hearing impairment | 27,422 | 9.17 | 20,296 | 74.01 | 7126 | 25.99 | ||
| Multiple disabilities | 25,472 | 8.52 | 21,753 | 85.4 | 3719 | 14.60 | ||
| Chronic mental health conditions | 24,642 | 8.24 | 17,517 | 71.09 | 7125 | 28.91 | ||
| Visual impairment | 17,569 | 5.87 | 13,985 | 79.6 | 3584 | 20.40 | ||
| Intellectual and developmental disability | 9671 | 3.23 | 8195 | 84.74 | 1476 | 15.26 | ||
| Dementia | 3794 | 1.27 | 3344 | 88.14 | 450 | 11.86 | ||
| Vocal and speech impairment | 2455 | 0.82 | 1914 | 77.96 | 541 | 22.04 | ||
| Motion and balance impairment | 803 | 0.27 | 621 | 77.33 | 182 | 22.67 | ||
| Facial disfigurements | 437 | 0.15 | 299 | 68.42 | 138 | 31.58 | ||
| Intractable epilepsy | 359 | 0.12 | 220 | 61.28 | 139 | 38.72 | ||
| Rare diseases | 85 | 0.03 | 66 | 77.65 | 19 | 22.35 | ||
| Autism | 65 | 0.02 | 50 | 76.92 | 15 | 23.08 | ||
| Otherb | 36 | 0.01 | 24 | 66.67 | 12 | 33.33 | ||
| < 0.001 | ||||||||
| Mild | 109,180 | 36.50 | 79,646 | 72.95 | 29,534 | 27.05 | ||
| Moderate | 97,543 | 32.61 | 75,641 | 77.55 | 21,902 | 22.45 | ||
| Severe | 50,611 | 16.92 | 42,619 | 84.21 | 7992 | 15.79 | ||
| Profound | 41,773 | 13.97 | 35,872 | 85.87 | 5901 | 14.13 | ||
| < 0.001 | ||||||||
| Male | 173,959 | 58.16 | 138,078 | 79.37 | 35,881 | 20.63 | ||
| Female | 125,148 | 41.84 | 95,700 | 76.47 | 29,448 | 23.53 | ||
| < 0.001 | ||||||||
| 50–59 | 175,332 | 58.62 | 123,047 | 70.18 | 52,285 | 29.82 | ||
| 60-69 | 123,775 | 41.38 | 110,731 | 89.46 | 13,044 | 10.54 | ||
| < 0.001 | ||||||||
| low income | 16,331 | 5.46 | 13,098 | 80.20 | 3233 | 19.80 | ||
| ≤ 17,280 | 17,382 | 5.81 | 14,585 | 83.91 | 2797 | 16.09 | ||
| 17,281-22,800 | 124,769 | 41.71 | 100,029 | 80.17 | 24,740 | 19.83 | ||
| 22,801-28,800 | 56,207 | 18.79 | 44,187 | 78.61 | 12,020 | 21.39 | ||
| 28,801-36,300 | 40,823 | 13.65 | 30,782 | 75.40 | 10,041 | 24.60 | ||
| ≥ 36,301 | 43,595 | 14.58 | 31,097 | 71.33 | 12,498 | 28.67 | ||
| < 0.001 | ||||||||
| Level 1 | 61,666 | 20.62 | 48,453 | 78.57 | 13,213 | 21.43 | ||
| Level 2 | 86,553 | 28.94 | 65,913 | 76.15 | 20,640 | 23.85 | ||
| Level 3 | 46,154 | 15.43 | 36,338 | 78.73 | 9816 | 21.27 | ||
| Level 4 | 55,312 | 18.49 | 43,918 | 79.40 | 11,394 | 20.60 | ||
| Level 5 | 10,177 | 3.40 | 7951 | 78.13 | 2226 | 21.87 | ||
| Level 6 | 21,069 | 7.04 | 16,581 | 78.70 | 4488 | 21.30 | ||
| Level 7 | 18,176 | 6.08 | 14,624 | 80.46 | 3552 | 19.54 | ||
| < 0.001 | ||||||||
| 0 | 131,068 | 43.82 | 100,118 | 76.39 | 30,950 | 23.61 | ||
| 1 | 63,076 | 21.09 | 47,143 | 74.74 | 15,933 | 25.26 | ||
| 2 | 42,825 | 14.32 | 33,660 | 78.60 | 9165 | 21.40 | ||
| ≥ 3 | 62,138 | 20.77 | 52,857 | 85.06 | 9281 | 14.94 | ||
| < 0.001 | ||||||||
| No | 227,891 | 76.19 | 187,709 | 82.37 | 40,182 | 17.63 | ||
| Yes | 71,216 | 23.81 | 46,069 | 64.69 | 25,147 | 35.31 | ||
| < 0.001 | ||||||||
| No | 221,087 | 73.92 | 184,436 | 83.42 | 36,651 | 16.58 | ||
| Yes | 78,020 | 26.08 | 49,342 | 63.24 | 28,678 | 36.76 | ||
a. FIT faecal immunochemical testing; b. Other: chromosomal abnormalities, inborn errors of metabolism, congenital defects; c. NT$ New Taiwan dollar; d. CCI Charlson comorbidity index.
Factors Associated with the Use of FIT for CRC Screening in People with Disability
| OR | 95% CI | |||
|---|---|---|---|---|
| Moving functional limitation (ref) | 1.00 | – | – | – |
| Internal organ function loss and related disabilities | 1.34 | 1.29 | 1.39 | < 0.001 |
| Hearing impairment | 1.22 | 1.18 | 1.26 | < 0.001 |
| Multiple disabilities | 1.00 | 0.96 | 1.05 | 0.885 |
| Chronic mental health conditions | 1.29 | 1.24 | 1.33 | < 0.001 |
| Visual impairment | 1.03 | 0.99 | 1.07 | 0.197 |
| Intellectual and developmental disability | 0.72 | 0.68 | 0.77 | < 0.001 |
| Dementia | 0.79 | 0.71 | 0.88 | < 0.001 |
| Vocal and speech impairment | 1.08 | 0.97 | 1.20 | 0.152 |
| Motion and balance impairment | 1.14 | 0.95 | 1.36 | 0.163 |
| Facial disfigurements | 1.17 | 0.94 | 1.45 | 0.166 |
| Intractable epilepsy | 1.47 | 1.17 | 1.85 | 0.001 |
| Rare diseases | 0.92 | 0.53 | 1.61 | 0.771 |
| Autism | 0.89 | 0.48 | 1.65 | 0.716 |
| Othera | 1.77 | 0.85 | 3.69 | 0.129 |
| Male (ref) | 1.00 | – | – | – |
| Female | 1.19 | 1.16 | 1.21 | < 0.001 |
| 50–59 (ref) | 1.00 | – | – | – |
| 60–69 | 0.23 | 0.22 | 0.23 | < 0.001 |
| Low income (ref) | 1.00 | – | – | – |
| ≤ 17,280 | 0.89 | 0.83 | 0.94 | < 0.001 |
| 17,281-22,800 | 1.07 | 1.02 | 1.12 | 0.007 |
| 22,801-28,800 | 1.05 | 1.00 | 1.10 | 0.048 |
| 28,801-36,300 | 1.17 | 1.11 | 1.23 | < 0.001 |
| ≥ 36,301 | 1.40 | 1.33 | 1.47 | < 0.001 |
| 1 (ref) | 1.00 | – | – | – |
| 2 | 1.14 | 1.11 | 1.17 | < 0.001 |
| 3 | 1.04 | 1.01 | 1.08 | 0.010 |
| 4 | 1.07 | 1.03 | 1.10 | < 0.001 |
| 5 | 1.34 | 1.26 | 1.42 | < 0.001 |
| 6 | 1.21 | 1.16 | 1.27 | < 0.001 |
| 7 | 1.13 | 1.08 | 1.18 | < 0.001 |
| 0 (ref) | 1.00 | – | – | – |
| 1 | 1.24 | 1.21 | 1.27 | < 0.001 |
| 2 | 1.22 | 1.19 | 1.26 | < 0.001 |
| ≥ 3 | 1.04 | 1.00 | 1.07 | 0.027 |
| Mild (ref) | 1.00 | – | – | – |
| Moderate | 0.85 | 0.84 | 0.87 | < 0.001 |
| Severe | 0.62 | 0.60 | 0.64 | < 0.001 |
| Profound | 0.56 | 0.54 | 0.59 | < 0.001 |
| No (ref) | 1.00 | – | – | – |
| Yes | 1.88 | 1.84 | 1.92 | < 0.001 |
| No (ref) | 1.00 | – | – | – |
| Yes | 3.32 | 3.25 | 3.39 | < 0.001 |
a. Others: chromosomal abnormalities, inborn errors of metabolism, and congenital defects; b. NT$ New Taiwan dollar; c. CCI Charlson comorbidity index.
Distribution after Matching between People with and without Disability
| Without disability | With disability | ||||||
|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | ||
| 550,580 | 100.00 | 275,290 | 50.00 | 275,290 | 50.00 | ||
| 0.671 | |||||||
| Male | 314,450 | 57.11 | 157,147 | 49.98 | 157,303 | 50.02 | |
| Female | 236,130 | 42.89 | 118,143 | 50.03 | 117,987 | 49.97 | |
| 0.961 | |||||||
| 50–59 | 325,450 | 59.11 | 162,716 | 50.00 | 162,734 | 50.00 | |
| 60–69 | 225,130 | 40.89 | 112,574 | 50.00 | 112,556 | 50.00 | |
| 0.845 | |||||||
| Low income | 11,586 | 2.10 | 5748 | 49.61 | 5838 | 50.39 | |
| ≤ 17,280 | 32,209 | 5.85 | 16,020 | 49.74 | 16,189 | 50.26 | |
| 17,281-22,800 | 233,047 | 42.33 | 116,651 | 50.05 | 116,396 | 49.95 | |
| 22,801-28,800 | 107,277 | 19.48 | 53,665 | 50.02 | 53,612 | 49.98 | |
| 28,801-36,300 | 80,211 | 14.57 | 40,130 | 50.03 | 40,081 | 49.97 | |
| ≥ 36,301 | 86,250 | 15.67 | 43,076 | 49.94 | 43,174 | 50.06 | |
| 0.891 | |||||||
| Level 1 | 117,180 | 21.28 | 58,542 | 49.96 | 58,638 | 50.04 | |
| Level 2 | 162,018 | 29.43 | 81,027 | 50.01 | 80,991 | 49.99 | |
| Level 3 | 86,586 | 15.73 | 43,364 | 50.08 | 43,222 | 49.92 | |
| Level 4 | 100,395 | 18.23 | 50,305 | 50.11 | 50,090 | 49.89 | |
| Level 5 | 17,408 | 3.16 | 8679 | 49.86 | 8729 | 50.14 | |
| Level 6 | 35,723 | 6.49 | 17,752 | 49.69 | 17,971 | 50.31 | |
| Level 7 | 31,270 | 5.68 | 15,621 | 49.96 | 15,649 | 50.04 | |
| 0.511 | |||||||
| 0 | 251,400 | 45.66 | 125,477 | 49.91 | 125,923 | 50.09 | |
| 1 | 122,117 | 22.18 | 61,131 | 50.06 | 60,986 | 49.94 | |
| 2 | 82,626 | 15.01 | 41,479 | 50.20 | 41,147 | 49.80 | |
| ≥ 3 | 94,437 | 17.15 | 47,203 | 49.98 | 47,234 | 50.02 | |
a. NT$ New Taiwan dollar; b. CCI Charlson comorbidity index.
Comparison of the Use of FIT for CRC Screening between People with and without Disability after Matching
| Without disability ( | With disability ( | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No FIT | FITa | No FIT | FIT | ||||||||
| N | % | N | % | N | % | N | % | N | % | ||
| 550,580 | 100.00 | 200,478 | 72.82 | 74,812 | 27.18 | 213,438 | 77.53 | 61,852 | 22.47 | < 0.001 | |
| Male | 314,450 | 57.11 | 117,974 | 75.07 | 39,173 | 24.93 | 123,868 | 78.74 | 33,435 | 21.26 | < 0.001 |
| Female | 236,130 | 42.89 | 82,504 | 69.83 | 35,639 | 30.17 | 89,570 | 75.92 | 28,417 | 24.08 | < 0.001 |
| 50–59 | 325,450 | 59.11 | 105,844 | 65.05 | 56,872 | 34.95 | 113,333 | 69.64 | 49,401 | 30.36 | < 0.001 |
| 60–69 | 225,130 | 40.89 | 94,634 | 84.06 | 17,940 | 15.94 | 100,105 | 88.94 | 12,451 | 11.06 | < 0.001 |
| Low income | 11,586 | 2.10 | 4630 | 80.55 | 1118 | 19.45 | 4614 | 79.03 | 1224 | 20.97 | 0.045 |
| ≤ 17,280 | 32,209 | 5.85 | 11,984 | 74.81 | 4036 | 25.19 | 13,486 | 83.30 | 2703 | 16.70 | < 0.001 |
| 17,281-22,800 | 233,047 | 42.33 | 86,836 | 74.44 | 29,815 | 25.56 | 92,579 | 79.54 | 23,817 | 20.46 | < 0.001 |
| 22,801-28,800 | 107,277 | 19.48 | 39,300 | 73.23 | 14,365 | 26.77 | 41,872 | 78.10 | 11,740 | 21.90 | < 0.001 |
| 28,801-36,300 | 80,211 | 14.57 | 28,509 | 71.04 | 11,621 | 28.96 | 30,176 | 75.29 | 9905 | 24.71 | < 0.001 |
| ≥ 36,301 | 86,250 | 15.67 | 29,219 | 67.83 | 13,857 | 32.17 | 30,711 | 71.13 | 12,463 | 28.87 | < 0.001 |
| Level 1 | 117,180 | 21.28 | 43,212 | 73.81 | 15,330 | 26.19 | 45,845 | 78.18 | 12,793 | 21.82 | < 0.001 |
| Level 2 | 162,018 | 29.43 | 58,012 | 71.60 | 23,015 | 28.40 | 61,078 | 75.41 | 19,913 | 24.59 | < 0.001 |
| Level 3 | 86,586 | 15.73 | 31,725 | 73.16 | 11,639 | 26.84 | 33,883 | 78.39 | 9339 | 21.61 | < 0.001 |
| Level 4 | 100,395 | 18.23 | 37,010 | 73.57 | 13,295 | 26.43 | 39,444 | 78.75 | 10,646 | 21.25 | < 0.001 |
| Level 5 | 17,408 | 3.16 | 6304 | 72.64 | 2375 | 27.36 | 6716 | 76.94 | 2013 | 23.06 | < 0.001 |
| Level 6 | 35,723 | 6.49 | 12,884 | 72.58 | 4868 | 27.42 | 14,057 | 78.22 | 3914 | 21.78 | < 0.001 |
| Level 7 | 31,270 | 5.68 | 11,331 | 72.54 | 4290 | 27.46 | 12,415 | 79.33 | 3234 | 20.67 | < 0.001 |
| 0 | 251,400 | 45.66 | 93,789 | 74.75 | 31,688 | 25.25 | 95,965 | 76.21 | 29,958 | 23.79 | < 0.001 |
| 1 | 122,117 | 22.18 | 43,133 | 70.56 | 17,998 | 29.44 | 45,505 | 74.62 | 15,481 | 25.38 | < 0.001 |
| 2 | 82,626 | 15.01 | 29,125 | 70.22 | 12,354 | 29.78 | 32,262 | 78.41 | 8885 | 21.59 | < 0.001 |
| ≥ 3 | 94,437 | 17.15 | 34,431 | 72.94 | 12,772 | 27.06 | 39,706 | 84.06 | 7528 | 15.94 | < 0.001 |
| No | 382,333 | 69.44 | 135,329 | 77.28 | 39,797 | 22.72 | 169,483 | 81.79 | 37,724 | 18.21 | < 0.001 |
| Yes | 168,247 | 30.56 | 65,149 | 65.04 | 35,015 | 34.96 | 43,955 | 64.56 | 24,128 | 35.44 | 0.043 |
| No | 379,637 | 68.95 | 140,250 | 78.95 | 37,383 | 21.05 | 167,375 | 82.86 | 34,629 | 17.14 | < 0.001 |
| Yes | 170,943 | 31.05 | 60,228 | 61.67 | 37,429 | 38.33 | 46,063 | 62.85 | 27,223 | 37.15 | < 0.001 |
| Moving Functional Limitation | 135,434 | 24.60 | 103,801 | 76.64 | 31,633 | 23.36 | |||||
| Internal organ function loss and related disabilities | 36,775 | 6.68 | 29,423 | 80.01 | 7352 | 19.99 | |||||
| Hearing impairment | 26,716 | 4.85 | 19,700 | 73.74 | 7016 | 26.26 | |||||
| Multiple disabilities | 21,919 | 3.98 | 18,602 | 84.87 | 3317 | 15.13 | |||||
| Chronic mental health conditions | 22,128 | 4.02 | 15,740 | 71.13 | 6388 | 28.87 | |||||
| Visual impairment | 16,430 | 2.98 | 12,981 | 79.01 | 3449 | 20.99 | |||||
| Intellectual and developmental disability | 8326 | 1.51 | 7070 | 84.91 | 1256 | 15.09 | |||||
| Dementia | 3521 | 0.64 | 3090 | 87.76 | 431 | 12.24 | |||||
| Vocal and speech impairment | 2318 | 0.42 | 1802 | 77.74 | 516 | 22.26 | |||||
| Motion and balance impairment | 770 | 0.14 | 596 | 77.40 | 174 | 22.60 | |||||
| Facial disfigurements | 426 | 0.08 | 289 | 67.84 | 137 | 32.16 | |||||
| Intractable epilepsy | 351 | 0.06 | 214 | 60.97 | 137 | 39.03 | |||||
| Rare diseases | 85 | 0.02 | 66 | 77.65 | 19 | 22.35 | |||||
| Autism | 57 | 0.01 | 42 | 73.68 | 15 | 26.32 | |||||
| Othersd | 34 | 0.01 | 22 | 64.71 | 12 | 35.29 | |||||
a. FIT faecal immunochemical testing; b. NT$ New Taiwan dollar; c. CCI Charlson comorbidity index; d. Others: chromosomal abnormalities, inborn errors of metabolism, and congenital defects.
Factors Associated with the Use of FIT for CRC Screening in People with and without Disability
| Model Aa | Model Ba | |||||||
|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||||
| Without (ref) | 1.00 | – | – | – | ||||
| With | 0.88 | 0.87 | 0.89 | < 0.001 | ||||
| Without disability (ref) | 1.00 | – | – | – | ||||
| Moving functional limitation | 0.81 | 0.77 | 0.84 | < 0.001 | ||||
| Internal organ function loss and related disabilities | 0.83 | 0.81 | 0.86 | < 0.001 | ||||
| Hearing impairment | 0.94 | 0.83 | 1.06 | 0.279 | ||||
| Multiple disabilities | 0.62 | 0.59 | 0.65 | < 0.001 | ||||
| Chronic mental health conditions | 1.04 | 1.01 | 1.08 | 0.035 | ||||
| Visual impairment | 1.09 | 1.05 | 1.13 | < 0.001 | ||||
| Intellectual and developmental disability | 0.53 | 0.49 | 0.56 | < 0.001 | ||||
| Dementia | 0.55 | 0.49 | 0.62 | < 0.001 | ||||
| Vocal and speech impairment | 0.90 | 0.89 | 0.92 | < 0.001 | ||||
| Motion and balance impairment | 0.95 | 0.78 | 1.16 | 0.636 | ||||
| Facial disfigurements | 1.17 | 0.92 | 1.50 | 0.208 | ||||
| Intractable epilepsy | 1.53 | 1.18 | 1.98 | 0.001 | ||||
| Rare diseases | 0.76 | 0.42 | 1.35 | 0.347 | ||||
| Autism | 0.85 | 0.42 | 1.73 | 0.653 | ||||
| Otherb | 1.45 | 0.64 | 3.32 | 0.376 | ||||
a. Both Model A and Model B controlled for seven control variables, namely, sex, age, monthly salary, urbanization level of the residential area, comorbidity severity, dental calculus cleaning, and free adult health examination; b. Others: chromosomal abnormalities, inborn errors of metabolism, and congenital defects.